Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 2
2009 1
2011 2
2012 4
2013 2
2014 2
2015 4
2016 5
2017 5
2018 6
2019 4
2020 3
2021 11
2022 7
2023 8
2024 8
2025 6
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VH, Dupui M, Ingelman-Sundberg M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Mitropoulou C, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, Dávila Fajardo CL, Dolžan V, Patrinos GP, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ; Ubiquitous Pharmacogenomics Consortium. Swen JJ, et al. Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4. Lancet. 2023. PMID: 36739136 Clinical Trial.
Pharmacogenetic polymorphisms affecting bisoprolol response.
Castaño-Amores C, Díaz-Villamarín X, Pérez-Gutiérrez AM, Antúnez-Rodríguez A, Pozo-Agundo A, Moreno-Escobar E, Sánchez-Ramos JG, Martínez-González LJ, Dávila-Fajardo CL. Castaño-Amores C, et al. Biomed Pharmacother. 2021 Oct;142:112069. doi: 10.1016/j.biopha.2021.112069. Epub 2021 Aug 27. Biomed Pharmacother. 2021. PMID: 34470728 Free article.
Next generation sequencing: an application in forensic sciences?
Alvarez-Cubero MJ, Saiz M, Martínez-García B, Sayalero SM, Entrala C, Lorente JA, Martinez-Gonzalez LJ. Alvarez-Cubero MJ, et al. Ann Hum Biol. 2017 Nov;44(7):581-592. doi: 10.1080/03014460.2017.1375155. Epub 2017 Sep 26. Ann Hum Biol. 2017. PMID: 28948844 Free article. Review.
Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: the al-Ándalus project.
Estévez-López F, Guerrero-González JM, Salazar-Tortosa D, Camiletti-Moirón D, Gavilán-Carrera B, Aparicio VA, Acosta-Manzano P, Álvarez-Gallardo IC, Segura-Jiménez V, Soriano-Maldonado A, Geenen R, Delgado-Fernández M, Martínez-González LJ, Ruiz JR, Álvarez-Cubero MJ. Estévez-López F, et al. Among authors: martinez gonzalez lj. Rheumatology (Oxford). 2022 Aug 3;61(8):3180-3191. doi: 10.1093/rheumatology/keab911. Rheumatology (Oxford). 2022. PMID: 34875034 Free PMC article.
The effects of a supervised exercise training program during pregnancy on placental cytokines, and the potential role of fetal sex and maternal weight status.
Acosta-Manzano P, Flor-Alemany M, Martínez-González LJ, Alvarez-Cubero MJ, Baena-García L, Nestares T, Van Poppel MNM, Aparicio VA. Acosta-Manzano P, et al. Among authors: martinez gonzalez lj. J Sport Health Sci. 2025 Sep 8;15:101082. doi: 10.1016/j.jshs.2025.101082. Online ahead of print. J Sport Health Sci. 2025. PMID: 40889575 Free PMC article.
Functional in vitro assessment of the HER2 Ile655Val variant on trastuzumab-induced cardiotoxicity in human cardiomyocytes.
Pozo-Agundo A, García-Rodríguez S, Antúnez-Rodríguez A, Chica-Redecillas L, Cejas RB, Lyra-Leite D, Porras-Quesada P, Gómez-Sánchez J, Mirón-Pozo B, Álvarez-Cubero MJ, Burridge PW, Martin F, Martínez-González LJ, Dávila-Fajardo CL. Pozo-Agundo A, et al. Eur J Pharmacol. 2026 Jan 20;1012:178484. doi: 10.1016/j.ejphar.2025.178484. Epub 2025 Dec 19. Eur J Pharmacol. 2026. PMID: 41423083
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity.
Martinez-Diz S, Morales-Álvarez CM, Garcia-Iglesias Y, Guerrero-González JM, Romero-Cachinero C, González-Cabezuelo JM, Fernandez-Rosado FJ, Arenas-Rodríguez V, Lopez-Cintas R, Alvarez-Cubero MJ, Martinez-Gonzalez LJ. Martinez-Diz S, et al. Hum Genomics. 2023 Jun 7;17(1):50. doi: 10.1186/s40246-023-00496-2. Hum Genomics. 2023. PMID: 37287057 Free PMC article.
Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19.
Martínez-Diz S, Marín-Benesiu F, López-Torres G, Santiago O, Díaz-Cuéllar JF, Martín-Esteban S, Cortés-Valverde AI, Arenas-Rodríguez V, Cuenca-López S, Porras-Quesada P, Ruiz-Ruiz C, Abadía-Molina AC, Entrala-Bernal C, Martínez-González LJ, Álvarez-Cubero MJ. Martínez-Diz S, et al. Among authors: martinez gonzalez lj. Front Immunol. 2023 Mar 8;13:1094644. doi: 10.3389/fimmu.2022.1094644. eCollection 2022. Front Immunol. 2023. PMID: 36969980 Free PMC article.
73 results